|
RNF26 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.904190E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.375000E-01 |
| Normal-vs-Stage2 |
1.221580E-02 |
| Normal-vs-Stage3 |
1.198380E-02 |
| Normal-vs-Stage4 |
7.927900E-02 |
| Stage1-vs-Stage2 |
1.322200E-03 |
| Stage1-vs-Stage3 |
1.416430E-04 |
| Stage1-vs-Stage4 |
1.891990E-02 |
| Stage2-vs-Stage3 |
7.424800E-01 |
| Stage2-vs-Stage4 |
5.878400E-01 |
| Stage3-vs-Stage4 |
7.572400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.281030E-01 |
| Normal-vs-AfricanAmerican |
5.217400E-01 |
| Normal-vs-Asian |
2.770800E-01 |
| Caucasian-vs-AfricanAmerican |
5.794100E-02 |
| Caucasian-vs-Asian |
6.556800E-01 |
| AfricanAmerican-vs-Asian |
2.821200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.837900E-02 |
| Normal-vs-Female |
9.746200E-01 |
| Male-vs-Female |
2.455700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.371200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.445800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.949700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.191800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.688800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.296000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.306990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.210160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.895250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.577400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.800940E-03 |
| Normal-vs-Grade 2 |
6.984400E-01 |
| Normal-vs-Grade 3 |
4.721500E-02 |
| Normal-vs-Grade 4 |
1.252580E-01 |
| Grade 1-vs-Grade 2 |
2.222400E-03 |
| Grade 1-vs-Grade 3 |
1.037640E-04 |
| Grade 1-vs-Grade 4 |
6.096200E-03 |
| Grade 2-vs-Grade 3 |
2.953800E-02 |
| Grade 2-vs-Grade 4 |
1.687980E-01 |
| Grade 3-vs-Grade 4 |
8.515000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.546600E-01 |
| Normal-vs-ccB subtype |
1.591050E-01 |
| ccA subtype-vs-ccB subtype |
1.623620E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.600600E-01 |
| Normal-vs-N1 |
4.277000E-01 |
| N0-vs-N1 |
8.437000E-01 |
|
|
